Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

February 2018 Analysis & Portfolio Holdings

|Includes: AbbVie Inc. (ABBV), ANTM, BLUE, BPMC, EXAS, FGEN, MAR, NKTR, NVDA, PYPL

Axcel Capital Management, LLC offers actively managed portfolios designed to identify and benefit from market trends that develop in individual stocks, sectors and industries; as well as take precautions to avoid downturns. As such, our portfolios take on a limited number of holdings representing areas of the market that are shown to be trending, based on our relative strength assessment. Below are our positions as of February 1st, 2018.

S&P 500 Relative Strength - Positive

Advantage Portfolio Holdings:

NVIDIA Corporation (NVDA) - initiated April 2017

Mariott International (MAR) - initiated April 2017

Paypal Holdings, Inc (PYPL)- initiated June 2017

Anthem, Inc (ANTM) - initiated May 2017

Abbvie, Inc (ABBV) - initiated October 2017

*No changes were made from previous month.

Premium Portfolio Holdings (in addition to Advantage Holdings):

Nektar Theraputics (NKTR) - initiated January 2018

Bluebird Bio, Inc (BLUE) - initiated January 2018

Exact Sciences Corp (EXAS) - initiated January 2018

Blueprint Medicines Corp (BPMC) - initiated January 2018

Fibrogen, Inc (FGEN) - initiated January 2018

*No changes were made from previous month.

Disclosure: I am/we are long NVDA, MAR, PYPL, ABBV, ANTM, NKTR, FGEN, EXAS, BLUE, BPMC.